Ari Levy

For New Enterprise Associates, its investment return on Tableau Software was — fittingly — off the charts. NEA’s $29.2 million stake in the digital chart provider, which made its stock market debut today, was valued at more than $925 million...

Keith Rabois successfully took on the finance and recruiting industries as an early executive at PayPal, LinkedIn and Square. A newly minted venture capitalist, Rabois’s next target is the similarly entrenched world of health care. After an alleged improper relationship,...

In 2010, Ben Milne made a journey across the Silicon Prairie for his first taste from the big tech trough. Then a twenty-something founder of a two-person startup in Iowa, Milne arrived in San Francisco with no business connections but a burning...

Nate Silver’s credibility may be at an all-time high. After accurately predicting how all 50 states (and the District of Columbia) would tilt in November’s presidential election, Silver’s FiveThirtyEight blog correctly picked Louisville to win the NCAA men’s basketball tournament...

Simon Roy prefers computers to professional money managers because machines don’t work on commission. The dark truth about the financial services industry is that brokers such as those found at a big bank branch or a strip mall often receive...

As co-founder of web startup 99designs, Matt Mickiewicz relied on 30 recruiters to find engineering talent for his company in the hyper-competitive market of San Francisco. Results were so poor that when one finally got a prospect hired, the recruiter...

For the second time in nine days, a high-ranking executive at the payments startup Square has landed in venture capital. This time, it’s Jared Fliesler, who served as a vice president of user acquisition and business operations at Square, the...

Welcome to the Draper University of Heroes, a new school in San Mateo, California, where aspiring entrepreneurs get a taste of the madness involved in running a startup. We featured the program in this week’s issue of Bloomberg Businessweek and...

Over the past half-decade, venture capitalists have been retreating from biotech and energy, burned by bad bets and turned off by excessive costs. Meanwhile, one firm with former executives from Pfizer and the Central Intelligence Agency is doubling down. Lux...